r/ASX

Who is in on DXN limited?
Have been following since the massive contract, which sent the stock nearly 6x.
I can see this continuing to blow up - its super quiet of forums which surprises me, interested to hear what people think.

Droneshield is a anti drone defence company in Australia. the share is down 30% in the last 6 months and with the prevalence of drone warfare around the world i feel this stock could blow up in the near future. There is some ingestion going on with them right now with there shares but i hear its nothing too major. any advice or information would be appreciated as someone whos a new investor.

Watching Wall Street have its best quarter in six years while we're basically flat year to date is genuinely frustrating. Every time there's a global rally it feels like we get a fraction of it and every time there's a selloff we get the full thing. Is this just how it is being an Australian investor or are people actually shifting money into global ETFs because of it.

Goldman cut WES to "sell" today on stretched valuations and a deteriorating risk-reward profile. Stock dropped 4% to $86.85

Wesfarmers is one of those names that always looks expensive and keeps going up anyway: Bunnings, Kmart, Officeworks, Priceline, the lithium play. The conglomerate discount argument never quite sticks because the earnings just keep compounding

But Goldman's not wrong that the valuation is stretched. And the Coles pet care acquisition talk ($4 billion for Greencross) suggests the big retailers are running out of organic growth and starting to buy it, which is rarely a great sign for multiples. And its no secret that a WES acquisition is on the cards. its a matter of when not if.

Is Goldman right that the risk-reward has turned, or is this just another sell rating that WES ignores on its way higher?

Been watching this one closely and wanted to put the pieces together for anyone else tracking it.

The Pro Medicus deal (25 June 2026)-

Pro Medicus (ASX: PME) — one of the most respected names in health imaging software globally — signed a binding Heads of Agreement with EchoIQ covering:

•	An initial A$10M investment via secured convertible notes, with an option for a further A$10M if EchoIQ’s EchoSolv HF gets FDA clearance

•	Notes carry 12.5% interest, convert at a A$1.05 cap (or lower via 5-day VWAP), plus 0.75 options per note struck at A$1.35

•	PME becomes a US reseller of EchoSolv, giving EIQ access to PME’s existing network of US health systems, academic medical centres, and enterprise healthcare customers via Visage 7 Cardiology

•	Definitive legal agreements were due within 20 business days of signing — worth checking ASX announcements for confirmation this has been finalised  

What’s happened since

•	1 July: EchoIQ raised A$110M at A$1.45/share from institutional and retail investors — company says it’s now fully funded for US commercialisation

•	New CFO and a structural-heart specialist added to the clinical network

•	Stock has run from well under A$1 to the \~A$1.60 range on the back of all this

The pending catalyst-

The big one is FDA clearance for EchoSolv HF (heart failure algorithm) — this is what unlocks PME’s second A$10M tranche and is the main re-rating catalyst people are watching for. Per the company’s own announcement, clearance “remains subject to regulatory review” with no guaranteed timeframe.

My take-

The PME tie-up is a real validation — PME doesn’t have to do deals like this, and getting picked as a reseller partner plus an equity backer says something about how they view EchoSolv’s clinical utility. Combined with the funding round, EIQ looks well capitalised to execute regardless of near-term dilution from the notes/options.

That said — worth being clear-eyed:
• FDA clearance is not guaranteed and timing on these things slips often
• Even with clearance, reimbursement (CPT coding) and actual uptake through PME’s channel are separate unproven steps
• The reseller agreement itself was still pending “definitive legal documentation” as of the HOA signing
• Stock has already re-rated a long way — a lot of good news may already be priced in
This is a binary, catalyst-driven microcap, not a “set and forget.” Sizing accordingly matters.

Disclosure: I hold EIQ. Not financial advice — do your own research.

24 Years Old, I invest every fortnight usually in STW or IVV. Any advice on my portfolio? Should I diversify more? Any sectors I'm missing out on? I'm more interested in long term investing, not touching for 10+ years.

Still a beginner, any advice is very appreciated.

https://preview.redd.it/tt3ch0pmopah1.png?width=2330&format=png&auto=webp&s=bb0307c2cd03377d3605a76787d22ee51095515f

Some etfs/ shares ASX200 FY 2026 performance .

A200 3.6%

STW 2.3%

MVB 2.8%

MVR 40%

OZR 46 %

IVV 15.3%

NDQ 26%

VGS 14.7%

MVA -1.7%

IEM 34.9 %

ASIA 94%

SEMI 162%

BHP 61.9%

RIO 62%

MQG 10%

CBA -10%

CSL - 52%

COH -59.9%

I've been watching SEEK for the past few weeks and can't decide whether the market has gone too far or is actually pricing in something real. AI is obviously changing the way people search for jobs, but I'm not convinced that means job boards suddenly become irrelevant.

Is this starting to look like a value opportunity, or do you think AI is a genuine long-term threat to SEEK's ANZ business?

I made a previous post lamenting on my extremely poorly performing speckies. NEU was actually also one of those who did really well when I first bought it, so I went and bought some more, then the whole lot plummeted deep into the red and I had regrets. I was almost 40% down when today I login to see it has gone up 36.48% today only!! It’s crazy it can increase that much in one day. Now I also hold onto hope for PCK, CAT and SGQ 🤞🏻😆

How can a stock increase that much in just one day?!

Profit downgrade on a spike up in bad loans, 3 customers across different sectors deteriorating at the same time apparently. 40% gone in one session — that's not a correction, that's the market questioning the entire business model.

NAB copped the contagion hardest, -3.4%, given it's got the most business lending exposure of the Big Four. ANZ, WBC and CBA all red too, just less brutal. (CBA briefly went green)

Im genuinely split on this one. Judo's a tiny challenger bank with a totally different loan book and risk profile to the majors — arguably this shouldn't spread. But "arguably shouldn't" is also what people said before contagion has spread plenty of times before.

NAB's chart looks awful

Is NAB's move just sympathy selling that fades, or is there real read-through risk here?

I saw a really nice dd on X, seems like a easy 10x if the scalability isn't a issue and we will find that out soon enough. Seems undervalued AF with all the positive stuff(facility acquired cheaply, world record GaN preformance, stacked team, no insider selling(there are a couple of small buys), big companies testing the product. What am I missing?

The DD I mentioned https://x.com/i/status/2062151966172541422.

There are considerable disagreements about the current price of Gold. Furthermore, the forces driving Gold prices often operate covertly or with hidden agendas, even at the expense of their own perceived objectives.

The US desires to quell emerging empires and the US debt mountain, appear central to this area of discussion, along with geopolitical impacts and the consequences that then transpire.

Often we work on assumptions that Gold is a safe haven attracting investors when confidence in other assets falls. Unfortunately, recent activities driven by US personal desires have pushed up demands for the USD, directly affecting DXY and the price of Gold.

Whilst there appears a correlation between DXY and Gold, what is driving the USD / DXY? Recently the Trump mandate was lower interest rates and a softer dollar to boost competitiveness. USD debt was sold aggressively by many countries, which favoured Gold. Then the new FED chairman arrives and appears to suggest an increase in interest rates. This seemingly soft comment sent the USD / DXY skyward and Gold down.

You have to question, if these actions and activities are all part of disruptive methodologies to, as ever, favour the US and keep the USD centre stage and in control.

During the Iran conflict Oil spiked and as it is priced in USD, some countries where selling Gold to buy USD to settle purchases. With the "strait" now open and Iranian assets being unfrozen, USD is again desirable as well as US debt.

When investing in the ASX, the impact of these actions play out in real-time. Share price changes often seem non sensical as the business has not changed nor has its ability to generate profit, however inflation and confidence erode the share price. If you are however a commodity, like a gold miner the impacts can be wild.

In discussions with well connected parties in SE Asia today, it was suggested the Gold cycle may have ended and it may just drift for the next few years between $3,000-3,800. If you then pick up the recent UBS report to clients, they state that the Gold price instability is a temporary measure whilst the issues relating to Iran conflict unwind. They further added that US interest rate rises are nonsense, the US debt mountain is worrying and Gold will recover and head towards $6,000 in the next 24 months.

Both views I suspect have validity but equally as we have seen when the new FED chairman arrived with a calming tone, that volatility is currently the new norm and both views may in fact have a playbook if conditions are met.

Challenging times ...

I’ve decided to take $5k out of my savings and invest it. How would you do it?
- 5k Lump sum?
- An extra 1k to my usually fortnightly investment amount for the next 5 fortnight’s?
- An extra $500 to my usually fortnightly investment for the next 10 fortnight’s?

I’m not really wanting to put it in all at once for dollar cost averaging but idk

For context i’ve got about 14k Invested, $1400 per fortnight 100% into DHHF.

I’m investing 100% DHHF for now until i learn more about investing and can decided on 3/4 ETF’s.

Might even say fuck it we ball and put 10k in too.

Hi All, interested in any advice / experience with companies providing trading updates in the so called 'confession season'. As an example, quite a few companies have provided trading updates recently informing the market of changes to earnings guidance. These are companies with a financial year end in June, in advance of reporting their results in August. My two questions are .... 1) do companies continue to provide trading updates in early July or is that considered too late and 2) if a company has not provided a trading update, is it likely their results in August will be within range of prior guidance?

Thanks alot for any thoughts!

Hey legends pretty new to all this, and currently investing in VDHG was just wondering would it be worth adding another etf to my portfolio or just be one and done

CCR closed down 9.09% today after confirming the ACCC has dragged its two main debt collection businesses, ARMA and Force Legal, into the Federal Court. The announcement was written to read as routine. The price reaction says otherwise.

The allegation is that ARMA and Force Legal breached the Australian Consumer Law in how they chased consumers over debts, across a period running from February 2022 to September 2025, with ARMA also accused of aiding and abetting Force Legal’s conduct. Both are wholly owned by CCR. The company denies the lot and says it’ll defend. It also says it cooperated through the investigation, that the ACCC is after a range of remedies, and that it can’t yet determine any financial impact.

That last part is what matters. Three and a half years of alleged conduct, a regulator asking for a range of remedies, and the company won’t put a number on the exposure.

ARMA isn’t some minor subsidiary. CCR paid around $46m for it in late 2021, a deal that more than doubled group revenue at the time and brought in 400-plus clients.

CCR is now a top-four collection agency in Australia, working for clients across transport, insurance, government, utilities and financial services. It doesn’t buy debt, it collects it on their behalf.

ARMA’s letters, texts, emails and calls hit a lot of Australians who’ve fallen behind on a bill. What the ACCC is going after is the core of the business, not an off-cut.

Now the part the market doesn’t seem to have run the numbers on.

CCR’s market cap is around $99m, on roughly 479m shares, with the stock down in the high teens of cents.

The penalty regime over most of the conduct window is brutal. Since November 2022 the maximum per contravention for a company is the greater of $50m, three times the benefit, or 30% of turnover over the period the breach ran. Before that it was $10m. Nearly the whole alleged period sits under the heavier one. The headline figure got doubled again to $100m earlier this year, but that only catches future conduct, not this.

And the recent penalties for this kind of thing are nine figures. Optus was hit with $100m last year for unconscionable conduct selling phones and contracts and the debt collection that followed. Qantas was $100m the year before. The old debt collection benchmark was ACM Group at $750,000 back in 2018 for harassing two vulnerable customers. Different world.

Then look at the balance sheet. CCR had about $21m cash at the end of December and posted a small statutory loss for the half. Market cap under $100m.

A penalty near the recent benchmarks is bigger than the entire company, and even a fraction of one moves the needle. That’s the imbalance, and it’s why the announcement is heavier than its tone lets on.

The other signal is who they’ve hired. ARMA and Force have retained Allan Myers AC KC. Myers is about as senior and as expensive as Australian barristers get. You don’t put someone of that calibre on a nuisance claim. Either they think it’s winnable, or it’s serious enough to throw everything at. Probably both.

The brand side stings too. CCR’s whole sell is softer, smarter, AI-assisted collections. The CEO’s statement today ran straight down that line, the bit about recovering what’s lawfully owed while respecting people’s rights and wellbeing, and the two not being in conflict.

ARMA markets something called a Resolve Policy built on empathy and ethical collections, and management has been talking up AI to handle inbound calls. A regulator alleging the opposite for three and a half years runs directly against that, and against every client renewal conversation happening right now.

If you’re newer to the sector, debt collection here is run against a joint ACCC and ASIC guideline known as RG96, which sets out the rules on how often you can contact someone, when, and what you can and can’t say to them.

And the timing isn’t isolated. The regulator has been steadily turning up the heat on the whole debt collection space, with bigger penalties, more court action, and a clear signal that the old “cost of doing business” approach to consumer conduct doesn’t fly anymore.

That’s worth thinking about for CCR specifically, because of how ARMA actually makes its money. It’s not a debt buyer. The PDL players buy bad debt for cents in the dollar and keep whatever they recover, so harder rules mostly squeeze their margin.

ARMA works on commission, it collects on behalf of the client and takes a cut of what comes in. So if a crackdown forces softer, slower, more compliant collection methods across the industry, recovery rates can drift down, and a commission model feels that directly in the top line.

Tighter conduct rules and lower collection rates aren’t just a legal problem for this business, they’re a revenue one. It’ll be interesting to watch how the whole sector’s collection performance holds up as the screws tighten.

The ACCC’s case is basically that the communications crossed those lines. That’s what it gets tested against.
None of this means CCR is cooked. The allegations are unproven and denied. We don’t know the scale yet, “certain consumers” could be a handful or thousands, and the statement of claim will tell us. Maximum penalties aren’t what courts actually hand down, they tend to land well under.

The business is still growing, guiding to $57m to $59m revenue and $9.5m to $10.5m EBITDA for FY26, and the acquisition amortisation that’s been dragging the bottom line drops off in early 2027. Early cooperation can count for a discount too if it gets that far.

What I’m watching from here.

The statement of claim, mainly how many consumers and how many contraventions, and whether the ACCC also runs the ASIC Act angle alongside the ACL.

Whether they take a provision at the next result, and how long “can’t determine” survives once the auditors are involved. Impeccable timing just days prior to June 30 and accounts closing off for the period. Clients going quiet at renewal. A trading halt or a capital raise, because fighting Myers isn’t cheap. And whether any individuals get named, since the regime carries personal liability.

One other thing worth a look while all this plays out. Sitting on CCR’s board is an “independent” director who also runs a training business that ARMA itself uses as a supplier.

Independent is doing some work in those quotes. A director whose other company earns money from the subsidiary now in front of the Federal Court over its conduct is the kind of related-party thread that’s easy to wave off in good times and a lot more awkward when the regulator is alleging that subsidiary’s practices broke the law. Worth asking how independent that oversight really is, and whether the training the board was paying for covered the exact conduct now at issue.

The bear case isn’t complicated. A microcap’s core business is being prosecuted by the regulator under a penalty regime that didn’t exist last time the sector got done over, the company won’t size the risk, and it’s hired one of the most expensive silk in the country to fight it.

Market cap is $99m. The recent comparable was $100m.

Not financial advice. Just numbers. Not a holder of CCR, been following for a while now.